WEX news & sentiment — WEX Inc.

MAY 22·GuruFocusMed

WEX Inc (WEX) Stock Up 3.5% and Still Undervalued -- GF Score: 83/100

WEX Inc (WEX) saw its shares rise 3.5% to $149.21, significantly below its GF Value™ estimate of $225.73, suggesting a potential undervaluation of 33.9%. Despite a high GF Score™ of 83/100, which indicates strong long-term potential, the company has a low financial strength rating and insiders have been net sellers, signaling possible caution. Investors are advised to consider the risks, including the potential for a value trap, despite the attractive current valuation.

MAY 21·Stock Titan

Director Groch adds 1,500 WEX (NYSE: WEX) shares in open-market buy

WEX Inc. director James R. Groch recently purchased 1,500 shares of the company's Common Stock in an open-market transaction at a price of $142.95 per share. This non-derivative acquisition increased his direct holdings to 17,957 WEX shares. The transaction, filed as a Form 4, indicates a positive sentiment towards the company from an insider.

MAY 19·Stock Titan

WEX (NYSE: WEX) director reports RSU grant and 1,567-share vesting

WEX Inc. director Derrick A. Roman reported recent equity compensation activities. On May 15, 2026, 1,567 Restricted Stock Units (RSUs) vested and converted into common shares, increasing his direct holdings to 6,434 shares. He also received a new grant of 1,605 RSUs on May 14, 2026, which are set to vest on May 14, 2027.

$WEX

WEX Inc (WEX) Stock Up 3.5% and Still Undervalued -- GF Score: 83/100

Director Groch adds 1,500 WEX (NYSE: WEX) shares in open-market buy

WEX (NYSE: WEX) director reports RSU grant and 1,567-share vesting

News on $WEX